Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
HUPO 2024
Programm
Poster
Personen
Suche
DE
Zurück
Poster viewing
Clinical Proteomics II
Termin
Datum:
Di., 22.10.
Zeit:
13:00
–
15:15
Ort / Stream:
Clinical Proteomics
Thema
Clinical Proteomics
Programm
Poster presentation
P-II-0618
Proteomic characterization of Meningioma tissue and serum
Julieta Maria Medaglia (Freiburg / DE)
Clinical Proteomics
Poster presentation
P-II-0619
Quantitative proteomics identifies proteins and pathways involved in the progression from precancerous gastric lesions in a population of high-cancer gastric risk
Lizeth Mejia (Cali / CO)
Clinical Proteomics
Poster presentation
P-II-0620
Assessment of Hemoglobin-related clinical markers using volumetric absorptive microsampling and data-independent acquisition mass spectrometry
Valdemir Melechco Carvalho (São Paulo / BR)
Clinical Proteomics
Poster presentation
P-II-0621
Harmonization of quantitative proteomics data collected across the international cancer proteogenome consortium
Gennifer E. Merrihew (Seattle, WA / US)
Clinical Proteomics
Poster presentation
P-II-0622
Integrative proteomic and AI-based histopathologic profiling reveals new prognostic subclusters in early-stage non-small cell lung cancer
Philipp Mertins (Berlin / DE)
Clinical Proteomics
Poster presentation
P-II-0623
Understanding the proteome changes arising throughout 5-Fluorouracil chemoresistance development in colorectal cancer cells, with special focus on the methyl proteome
Isaac Micallef (Msida / MT)
Clinical Proteomics
Poster presentation
P-II-0624
ACR-2316: a potent, selective WEE1/PKMYT1 inhibitor rationally designed for superior single agent activity using Acrivon Predictive Precision Proteomics (AP3) for biological SAR
Georgia Mitsa (Lund / SE)
Clinical Proteomics
Poster presentation
P-II-0625
Targeted quantitative proteomics of anticoagulated patients
Yassene Mohammed (Leiden / NL)
Clinical Proteomics
Poster presentation
P-II-0626
Proteomic mapping of spatiotemporal dynamics in metastatic colorectal cancer
Vishnu Mohan (Rehovot / IL)
Clinical Proteomics
Poster presentation
P-II-0628
The promise of the Orbitrap ASTRAL mass-spectrometer for proteomics analysis
Jean-Marc Monneuse (Lyon / FR)
Josephine Abi Ghanem (Lyon / FR)
Adrien Saliou (Villeurbanne / FR)
Clinical Proteomics
Poster presentation
P-II-0629
Circulating plasma and salivary extracellular vesicles proteomes indicate prognostic signature in oral cancer
Carolina Moretto Carnielli (Campinas / BR)
Clinical Proteomics
Poster presentation
P-II-0630
The forgotten success story of clinical proteomics: how autoantibodies discovered via proteomics tools are now key diagnostic biomarkers in neurology
Christian Moritz (Saint-Étienne / FR)
Clinical Proteomics
Poster presentation
P-II-0631
Optimizing capivasertib response prediction in cancer: unveiling resistance mechanisms through precision proteomics
Neginsadat Mostolizadeh (Montreal / CA)
Clinical Proteomics
Poster presentation
P-II-0632
Quantification of Her2 expression in Her2-low tumors by targeted mass spectrometry
Negarsadat Mostolizadeh (Montreal / CA)
Clinical Proteomics
Poster presentation
P-II-0633
Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk
Robert Moulder (Turku / FI)
Clinical Proteomics
Poster presentation
P-II-0634
Proteomic signatures of the eutopic endometrium of patients with deep bowel endometriosis
Arlindo Moura (Fortaleza / BR)
Clinical Proteomics
Poster presentation
P-II-0635
Evaluation of new sample preparation methods associated with DIA analysis on Exploris 480 and Tims Tof SCP mass spectrometers to increase proteomic depth on plasma
Emmanuelle Mouton-Barbosa (Toulouse / FR)
Clinical Proteomics
Poster presentation
P-II-0636
Why is the peripartum heart a substrate for dilated cardiomyopathy? A data driven investigation of molecular and cellular remodelling.
John Mulvey (Copenhagen / DK)
Clinical Proteomics
Poster presentation
P-II-0637
Peptidomic analysis of cerebrospinal fluid samples reveals new biomarker candidates for amyotrophic lateral sclerosis
Besnik Muqaku (Ulm / DE)
Clinical Proteomics
Poster presentation
P-II-0638
Differentially expressed protein biomarkers in early and advanced stage of young triple-negative breast cancer patients
Shamim Mushtaq (Karachi / PK)
Clinical Proteomics
Poster presentation
P-II-0639
Plasma proteome profiling revealed altered levels of complements in the plasma of interverterbal disc degeneration patients
Sharon Miracle Nayagam (Coimbatore / IN)
Clinical Proteomics
Poster presentation
P-II-0640
Plasma proteome profiling revealed altered levels of complements in the plasma of interverterbal disc degeneration patients
Sharon Miracle Nayagam (Coimbatore / IN)
Clinical Proteomics
Poster presentation
P-II-0641
Comparative proteomic analysis of breast cancer and normal tissues with deep plasma profiling using the Mag-Net™ workflow
Adele Nel (Pretoria / ZA)
Clinical Proteomics
Poster presentation
P-II-0642
Protein-profiling of liquid biopsies for the differential diagnosis of pancreatic diseases
Thao Vi Nguyen (Luebeck / DE)
Clinical Proteomics
Poster presentation
P-II-0643
Cell lines recapitulate the kinase activity profiles of colorectal tumor tissue and predict drug response
Rei Noguchi (Tokyo / JP)
Clinical Proteomics
Poster presentation
P-II-0644
A proteomic skin disease atlas for accurate and rapid AI-driven clinical decision making
Thierry M. Nordmann (Planegg / DE)
Clinical Proteomics
Poster presentation
P-II-0645
A translational, high-throughput proteomics platform for the deep analysis of plasma samples
Estefanía Núñez (Madrid / ES)
Clinical Proteomics
Poster presentation
P-II-0646
ZenoSWATH proteomics and clustering analysis reveal different modulation patterns in fibroblasts from cystinosis patients by cysteamine
Ignacio Ortea (Oviedo / ES)
Clinical Proteomics
Poster presentation
P-II-0647
Pharmaco-proteogenomics for synovial sarcoma towards novel therapy
Julia Osaki (Tokyo / JP)
Clinical Proteomics
Poster presentation
P-II-0648
The European cancer moonshot "Biobank" – the heart of cancer studies
Henriett Oskolás (Lund / SE)
Clinical Proteomics
Poster presentation
P-II-0649
Predicting abdominal aortic aneurysms by combining mass spectrometry-based proteomics with clinical data
Nicolai Bjødstrup Palstrøm (Odense / DK)
Clinical Proteomics
Poster presentation
P-II-0650
Proteome analysis with combined DIA and Glyco‑DIA approach of laser microdissected precursor lesions from pancreatobiliary cancer to improve early cancer diagnostics
Stella Maris Pauls (Duesseldorf / DE)
Clinical Proteomics
Poster presentation
P-II-0651
Clinical proteomics elucidated the complex molecular mechanisms in the progression of dry eye syndrome with different severity levels: a step forward to personalized diagnosis
Natarajan Perumal (Mainz / DE)
Clinical Proteomics
Poster presentation
P-II-0652
Development of a plasma proteomics methodology for biomarker discovery of immunocytokine therapy in Glioblastoma
Lucrezia Principi (Otelfingen / CH)
Clinical Proteomics
Poster presentation
P-II-0653
Saliva peptidome as source of possible biomarkers of salivary glands tumor
Michał Puchalski (Gdansk / PL)
Clinical Proteomics
Poster presentation
P-II-0654
Time-resolved plasma proteomics predicts survival outcome of COVID-19 patients during hospitalization
Mauricio Quiñones-Vega (Rio de Janeiro / BR)
Clinical Proteomics
Poster presentation
P-II-0655
Profiling of the pathophysiological mediators of a rare neurodegenerative disease, Friedreich's Ataxia (FRDA)
Jannatul Rafeya (Aachen / DE)
Clinical Proteomics
Poster presentation
P-II-0656
Requirements and limitations for the preparation of targeted mass spectrometry assays enabling therapeutic drug monitoring
Yvonne Reinders (Dortmund / DE)
Clinical Proteomics
Poster presentation
P-II-0657
Proteomics signature predictive of early biochemical progression and distant progression after stereotactic body radiotherapy in oligometastatic prostate cancer
Ombretta Repetto (Aviano / IT)
Clinical Proteomics
Poster presentation
P-II-0658
Comparative proteomic analysis of human ventricular tissue of over 100 patients undergoing heart transplantation
Ulrike Resch (Vienna / AT)
Clinical Proteomics
Poster presentation
P-II-0659
A high-throughput, in-depth investigation into the immunological effects of Lipopolysaccharide challenged mice in neat plasma on Orbitrap astral mass spectrometer
Jana Richter (Bremen / DE)
Clinical Proteomics
Poster presentation
P-II-0660
Quality control for clinical proteomics
Svitlana Rozanova (Bochum / DE)
Clinical Proteomics
Poster presentation
P-II-0661
An in-depth and high throughput plasma proteomics workflow powered by Orbitrap Exploris 480 mass spectrometer using multi nanoparticle-based workflow
Julian Saba (Winnipeg / CA)
Clinical Proteomics
Poster presentation
P-II-0662
Deep plasma proteomics profiling of healthy humans at two different stages of adulthood
Eduard Sabidó (Barcelona / ES)
Clinical Proteomics
Poster presentation
P-II-0663
Quantification of intra-amniotic inflammation in late preterm prelabor rupture of membranes associated with the response of amniotic fluid proteome
Michaela Sadibolova (Hradec Kralove / CZ)
Clinical Proteomics
Poster presentation
P-II-0664
Biomarker discovery through in-depth characterisation of the serum protein composition of infant victims of silent Abusive Head Trauma (AHT)
Tatjana Sajic (Lausanne / CH)
Clinical Proteomics
Poster presentation
P-II-0665
Search for novel diagnostic markers of pancreatic ductal adenocarcinoma using secretome and glycoproteom analysis
Yoshino Sakuma (Sagamihara-City / JP)
Clinical Proteomics
Poster presentation
P-II-0666
Vasodilator-stimulated phosphoprotein acts as a potential plasma-derived exosomal protein marker for early detection of colorectal cancer
Juthaporn Sangwallek (Bangkok / TH)
Clinical Proteomics
Poster presentation
P-II-0667
Sample storage as pre-analytical factor on serum proteome quality
Thorben Sauer (Luebeck / DE)
Clinical Proteomics
Poster presentation
P-II-0668
Profiling of the global proteome and the repertoire of N-termini of vitreous humor uncovers alterations of cell adhesiveness and extracellular matrix composition in rhegmatogenous retinal detachment
Diego Sbardella (Rome / IT)
Clinical Proteomics
Poster presentation
P-II-0669
Endoscope-based cold atmospheric Plasma (PLASMASKOP) as a novel therapeutic tool for the treatment of head and neck cancer
Christian Scharf (Greifswald / DE)
Clinical Proteomics
Poster presentation
P-II-0670
Plasma proteome profiling reveals immunological dynamics in a longitudinal yellow FeverVaccination cohort
Alicia-Sophie Schebesta (Planegg / DE)
Clinical Proteomics
Poster presentation
P-II-0671
Enriching the diagnostic portfolio of the molecular tumor board with proteomics and phosphoproteomics of FFPE samples
Oliver Schilling (Freiburg / DE)
Clinical Proteomics
Poster presentation
P-II-0672
Phosphoproteomics adds value to treatment recommendations in molecular tumor boards
Annika Schneider (Freising / DE)
Clinical Proteomics
Poster presentation
P-II-0673
Workflow for rapid proteome and phosphoproteome profiling of aging in mouse tissues
Felix Schneidmadel (Jena / DE)
Clinical Proteomics
Poster presentation
P-II-0674
Tumour cell-induced platelet aggregation revealed different phenotypes between PDAC plasticity subtypes – A proteomic comparison between two pancreatic cancer cell lines
Katharina Schulz (Luebeck / DE)
Clinical Proteomics
Poster presentation
P-II-0675
Exploring extracellular vesicle proteins as source of biomarkers for early detection of meningioma and predicting their therapeutic implications
Swati Sharma (New Delhi / IN)
Clinical Proteomics
Poster presentation
P-II-0676
Search for novel diagnostic markers of chronic kidney disease in cats using proteome analysis
Momori Shimizu (Sagamihara-City / JP)
Hiroto Maeda (Tomakomai-city / JP)
Yoshio Kodera (Sagamihara-City / JP)
Kazuyuki Sogawa (Sagamihara-City / JP)
Clinical Proteomics
Poster presentation
P-II-0677
Search for novel diagnostic markers of pancreatic ductal adenocarcinoma using secretome and proteome analysis
Noriaki Shinoda (Sagamihara-City / JP)
Clinical Proteomics
Poster presentation
P-II-0678
Intra-sample three-point quantitative calibration using metabolically labelled QconCATs
Florian Christoph Sigloch (Bad Abbach / DE)
Clinical Proteomics
Poster presentation
P-II-0679
Transmembrane glycoprotein GPNMB is a candidate predictive biomarker and potentially a therapeutic target in metastatic renal cell carcinoma
Jan Simonik (Brno / CZ)
Clinical Proteomics
Poster presentation
P-II-0680
FFPE tissue proteomics (LC-MS/MS): applications in diagnostic molecular pathology
Stephan Singer (Tuebingen / DE)
Clinical Proteomics
Poster presentation
P-II-0681
Proteomics-driven biomarker discovery for M3913 in multiple myeloma xenograft models
Jasjot Singh (Darmstadt / DE)
Clinical Proteomics
Poster presentation
P-II-0682
Proteomic remodeling of the heart following transplantation: the signature of cardiac allograft vasculopathy
Mikkel Skjoldan Svenningsen (Copenhagen / DK)
Clinical Proteomics
Poster presentation
P-II-0683
Search for novel diagnostic markers of pancreatic ductal adenocarcinoma using secretome analysis
Kazuyuki Sogawa (Sagamihara-City / JP)
Clinical Proteomics
Poster presentation
P-II-0684
The PATH biobank – fostering breast cancer research
Franziska Sommermeyer (Munich / DE)
Heinz Bodenmüller (Munich / DE)
Clinical Proteomics
Poster presentation
P-II-0685
Analysis of women's health-related proteins in dried blood spots
William Stauch (Stockholm / SE)
Clinical Proteomics
Poster presentation
P-II-0686
Identifying new immunotherapy targets for pediatric leukemia using cell surface proteome profiling.
Kelly Stecker (Utrecht / NL)
Clinical Proteomics
Poster presentation
P-II-0687
Single Cell Deep Visual Proteomics (scDVP) of human hepatocytes in alpha-1 antitrypsin deficiency
Sophia Steigerwald (Munich / DE)
Clinical Proteomics
Poster presentation
P-II-0688
MultiOmics landscape of pathotypes in rheumatoid arthritis – enroute to digital health using AI clinical diagnostics by nanoproteomics and AI based imaging diagnostics
Allan Stensballe (Gistrup / DK)
Clinical Proteomics
Poster presentation
P-II-0689
An end-to-end (phospho)proteomics data analysis platform for precision oncology of 1000 prospective pan-cancer patients
Matthew The (Freising / DE)
Clinical Proteomics
Poster presentation
P-II-0690
Insights from proteomic analysis in Crohn's disease
Johanna Thiery (Freiburg / DE)
Clinical Proteomics
Poster presentation
P-II-0692
Towards a noninvasive diagnosis of Peri-implantitis: proteomic analysis of Peri-implant crevicular fluid
Annika Topitsch (Freiburg / DE)
Clinical Proteomics
Poster presentation
P-II-0693
Comparative proteomic analysis of laser microdissected human glomeruli and tubules in IgA nephropathy
Yudai Tsuji (Aichi / JP)
Clinical Proteomics
Poster presentation
P-II-0694
Proteogenomic profiling of mutated proteins in urine extracellular vesicles for non-invasive bladder cancer liquid biopsy
Koji Ueda (Koto-ku / JP)
Clinical Proteomics
Poster presentation
P-II-0695
Early detection of liver cancer – the role of extracellular matrix proteins
Henry Unger (Heidelberg / DE)
Clinical Proteomics
Poster presentation
P-II-0696
Efficient Human Plasma Proteome Profiling at up to 240 Samples Per Day
Natalie Van Landuyt (Zwijnaarde / BE)
Clinical Proteomics
Poster presentation
P-II-0697
Ultra-deep MS based plasma proteomics in a hand foot and mouth disease cohort
Iolanda Vendrell (Oxford / GB)
Clinical Proteomics
Poster presentation
P-II-0698
Multiplex mass spectrometry-based analysis of inflammatory proteins and their isoforms in serum samples of analog astronauts
Veronika Vidova (Brno / CZ)
Clinical Proteomics
Poster presentation
P-II-0699
Loss of SDHB manifests differently in the proteomes of neuroendocrine tumors and a tumor-derived cell line model hPheo-1
Ondrej Vit (Vestec / CZ)
Clinical Proteomics
Poster presentation
P-II-0700
Urinary proteome profiling of rat and human unveils biomarkers of LRRK2 activity
Duc Tung Vu (Munich / DE)
Clinical Proteomics
Poster presentation
P-II-0701
Proteomic profiling of progressive multiple sclerosis patient brains reveals regional and cell-type protein differences related to disease processes
Henry Wang (Edmonton / CA)
Clinical Proteomics
Poster presentation
P-II-0702
Dynamic proteomic changes in tumor and immune organs reveal systemic immune response to tumor development
Yi Wang (Hangzhou / CN)
Clinical Proteomics
Poster presentation
P-II-0703
TMT proteomics reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes
Sophia Weiner (Mölndal / SE)
Clinical Proteomics
Poster presentation
P-II-0704
Proteomic profiling of IDH-wildtype glioblastoma reveals prognostic subtypes with matching abundances of semi-specific peptides in serum
Tilman Werner (Freiburg / DE)
Clinical Proteomics
Poster presentation
P-II-0705
Monitoring disease status and treatment performance in multiple myeloma
Charissa Wijnands (Nijmegen / NL)
Clinical Proteomics
Poster presentation
P-II-0706
dia-PASEF proteomic analysis of HNSCC tumor and stroma enriched sections from FFPE samples prepared with laser capture microdissection
Pierre-Olivier Schmit (Paris / FR)
Clinical Proteomics
Poster presentation
P-II-0707
Morphological and molecular profiling as a pilar of precision medicine: tailoring treatment in late-stage cancer patients
Nicole Woldmar (Malmö / SE)
Clinical Proteomics
Poster presentation
P-II-0708
Leveraging the Orbitrap astral mass spectrometer to enable the analysis of low tissue content sample sources
Dylan Xavier (Westmead / AU)
Clinical Proteomics
Poster presentation
P-II-0709
Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes
He-Li Xu (ShenYang / CN)
Clinical Proteomics
Poster presentation
P-II-0710
Comparative analysis of EV isolation method for urinary extracellular vesicles proteomics in cancer
Lijie Xu (Amsterdam / NL)
Clinical Proteomics
Poster presentation
P-II-0711
Proteomics-guided personalized therapy for advanced primary uterus diffuse large B-cell lymphoma: a case report
Xizhen Xu (Wuhan / CN)
Clinical Proteomics
Poster presentation
P-II-0712
Reproducibility and reliability of protein quantity analyzed by DIA quantitative proteomics for urine biomarker discovery
Keiko Yamamoto (Niigata / JP)
Clinical Proteomics
Poster presentation
P-II-0713
Urine bank in biofluid biomarker center and its usability for biomarker discovery
Tadashi Yamamoto (Niigata / JP)
Clinical Proteomics
Poster presentation
P-II-0714
Discovery and validation of urine biomarkers for kidney nephron/site-specific damages by proteomics and immunoassay
Kengo Yanagita (Niigata / JP)
Clinical Proteomics
Poster presentation
P-II-0715
Unlocking biomarker discovery with novel high-throughput LC-MS workflows for translational research on an Orbitrap Astral mass spectrometer
Kevin Yang (San Jose, CA / US)
Clinical Proteomics
Poster presentation
P-II-0717
Discrepancies in proteomics data: autopsy versus fresh frozen samples
Xiaoke Yin (London / GB)
Clinical Proteomics
Poster presentation
P-II-0718
Proteomics identifies circulating TIMP-1 as a prognostic biomarker for diffuse large B-Cell Lymphoma
Xiaobo Yu (Beijing / CN)
Clinical Proteomics
Poster presentation
P-II-0719
Structure-based protein biomarkers for early detection of breast cancer
Boris Zaslavsky (Cleveland, OH / US)
Clinical Proteomics
Poster presentation
P-II-0720
High-throughput peptidome profiling reveals Ischemic stroke-specific proteolysis changes in plasma
Andreas Zellner (Freising / DE)
Clinical Proteomics
Poster presentation
P-II-0721
Cross-platform proteomic profiling of plasma extracellular vesicles to identify biomarkers of malignant pulmonary modules
Liang ZHANG (Hong Kong / HK)
Clinical Proteomics
Poster presentation
P-II-0722
The molecular insights into the glomerulus injury and prognosis of patients with diabetic kidney disease by integrating proteomics and single-sell RNA sequencing
Tingting Zhao (nanjing / CN)
Clinical Proteomics
Poster presentation
P-II-0723
Proteomic and gene panel-based profiling of medullary thyroid cancer for prognosis prediction
Yan Zhou (Hangzhou / CN)
Clinical Proteomics
v1.19.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz